School of Medicine
Showing 1-100 of 1,011 Results
-
Aysha Abraibesh
Clinical Research Coordinator Associate, Psych/General Psychiatry and Psychology (Adult)
Bio Aysha Abraibesh, MPA is a clinical research coordinator in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. She works primarily on the Stanford Apnea and Insomnia Study (AIR) Study, led by Dr. Rachel Manber (more info can be found at airstudy.stanford.edu)
Aysha earned her Bachelor’s degree in Psychology (2012) and Master’s in Public Administration (2013) both from Clark University in Worcester, Massachusetts. She has since held multiple positions supporting research studies related to social and behavioral health issues, most recently as a Lead Behavioral Health Interviewer at Kaiser Permanente’s Center for Health Research in Portland, Oregon. -
Daniel Arthur Abrams
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Language impairments affect up to 19% of school age children and these deficits are predictive of long-term problems affecting learning, academic achievement, and behavior. My primary research goal is to understand the neurobiological foundations of language impairments. Specifically, I am interested in how the perception and neural coding of speech impact language and other behavioral deficits in children, with a focus on children with reading disabilities and autism spectrum disorders.
-
Ehsan Adeli Mosabbeb
Instructor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests My research lies in the intersection of Machine Learning, Computer Vision and Medical Imaging.
-
Steven Adelsheim
Clinical Professor, Psychiatry and Behavioral Sciences
Bio Steven Adelsheim, MD is a child/adolescent and adult psychiatrist who works to support community behavioral health partnerships locally, regionally, at the state level and nationally. He is the Director of the Stanford Center for Youth Mental Health and Wellbeing in the Department of Psychiatry. Dr. Adelsheim has partnered in developing statewide mental health policy and systems, including those focused on school mental health, telebehavioral health, tribal behavioral health programs, and suicide prevention. For many years Dr. Adelsheim has been developing and implementing early detection/intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, prodromal symptoms of psychosis, and first episodes of psychosis. Dr. Adelsheim is also involved in the implementation of integrated behavioral health care models in primary care settings as well as the use of media to decrease stigma surrounding mental health issues. He is currently leading the US effort to implement the headspace model of mental health early intervention for young people ages 12-25 based in Australia. Dr. Adelsheim also leads the national clinical network for early psychosis programs called PEPPNET.
-
Sarah Adler
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests I am interested in the design and delivery of clinical care using, data and technology. I have focused on disordered eating behaviors and obesity.
-
W. Stewart Agras
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly Interests My research is focused on disorders of human feeding including the eating disorders: anorexia nervosa, bulimia nervosa, and binge eating disorder. Ongoing or recently completed studies include: A controlled trial of the implementation of interpersonal psychotherapy for eating disorders and depression on college campuses across the U.S. A multisite controlled study of two types of family therapy for the treatment of adolescent anorexia nervosa. Early prevemtion of overweight and obesity.
-
Raag Airan
Assistant Professor of Radiology (Neuroradiology) at the Stanford University Medical Center and, by courtesy, of Materials Science and Engineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Our goal is to develop and clinically implement new technologies for high-precision and noninvasive intervention upon the nervous system. Every few millimeters of the brain is functionally distinct, and different parts of the brain may have counteracting responses to therapy. To better match our therapies to neuroscience, we develop techniques that allow intervention upon only the right part of the nervous system at the right time, using technologies like focused ultrasound and nanotechnology.
-
Ronald Albucher
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center
Bio Dr. Ronald Albucher is the former Director of Counseling and Psychological Services at Vaden Health Center. His undergraduate training was at University of Pennsylvania and he attended University of Michigan for medical school and residency. Dr. Albucher subsequently joined the faculty at the University of Michigan Medical School’s Department of Psychiatry, where he specialized in Anxiety Disorders, Mental Health treatment of university residents and medical students, and also ran the Ann Arbor VA Medical Center’s Mental Health Clinic. Dr. Albucher was the Associate Training Director, University of Michigan, Department of Psychiatry for approximately 10 years. Ron has been very involved in organized psychiatry, holding numerous positions with the American Psychiatric Association, Michigan Psychiatric Society, and the Northern California Psychiatric Society.
Ron joined Stanford University in September 2008, when he became Director of Counseling and Psychological Services, and a Clinical Associate Professor of Psychiatry in the Medical School’ s Department of Psychiatry. Dr. Albucher has presented at a variety of conferences, published two books on Board Review, and has published scientific research in peer reviewed journals. He continues to serve on the review boards of several journals and publications and is working on two projects currently: eBridge to Wellness (a multisite study of online based outreach to at risk college students), and investigating the implementation of a short-term psychotherapy model in college counseling centers. He stepped down from the Director position in September 2018. -
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests College Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Neal Dilip Amin
Resident in Psychiatry and Behavioral Sciences
Bio Neal D. Amin, MD, PhD received his bachelors in Biochemistry from Columbia University where he studied the structure-function relationship of neurexins and neuroligins, proteins implicated in familial autism. He continued his research interests as a medical and doctoral student at the University of California, San Diego in the Medical Scientist Training Program (MD/PhD). Dr. Amin's doctoral research was conducted at the Salk Institute for Biological Studies in the laboratory of Howard Hughes Medical Investigator Samuel Pfaff, where he studied spinal cord development and neurodegenerative disease. He used transcriptomics, mouse genetics, and deep phenotyping to uncover novel gene regulatory pathways driving the establishment of neuronal identity and function. Dr. Amin is currently a resident physician in the research track in the Department of Psychiatry and Behavioral Sciences at Stanford University with a particular interest in neurobiology and understanding molecular mechanisms behind neuropsychiatric disease. Within the lab of Dr. Sergiu Pasca, he uses human brain organoids derived from induced pluripotent stem cells to model neurodevelopment and neuropsychiatric disease.
-
Dr Kathleen Carrie Armel
Affiliate, Psych/General Psychiatry and Psychology (Adult)
Bio Dr. Carrie Armel is a research associate at Stanford’s Precourt Energy Efficiency Center (PEEC) where she investigates the diverse ways in which an understanding of human behavior can lead to improvements in energy efficiency. For example, the application of behavioral principles can produce significant energy reductions through interventions implemented at the policy, technology, built environment, media/marketing, and organizational/community levels. Dr. Armel co-chairs the Behavior, Energy, and Climate Change Conference; oversees Precourt Institute’s Behavior and Energy Bibliographic Database and Website; and teaches courses on behavior and energy at Stanford.
In addition to these initiatives, Dr. Armel develops specific energy efficiency interventions that apply behavioral and design principles, and develops measures to evaluate the efficacy of such interventions. Her most recent project involves a collaboration between academic and non-academic organizations to design and evaluate a technology that takes advantage of smart meters to provide feedback to residents on home electricity use.
Dr. Armel completed a Ph.D. in Cognitive Neuroscience from the University of California at San Diego, and postdoctoral work in Neuro-Economics at Stanford. In these programs she employed behavioral, psychophysiological, and neuroscientific methods to investigate how affect and motivation influence behavior. She most recently completed postdoctoral work at Stanford’s School of Medicine, translating intervention techniques used in health promotion work into the domain of energy efficiency. -
Bruce Arnow, Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) at the Stanford University Medical Center
Current Research and Scholarly Interests Current research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.
-
Naoyuki Asada
Affiliate, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Bio Education:
- Bachelor of Science, University of Tokyo (2007)
- Master of Science, University of Tokyo (2009)
- Doctor of Philosophy, University of Tokyo (2012)
Professional Experience:
- Pharmacological Researcher, Daiichi-Sankyo Co., Ltd. (2012-present) -
Mehret Assefa
Program Manager, Psych/Public Mental Health & Population Sciences
Bio Mehret Assefa, PhD, MPH is the Program Manager for the Center for Behavioral Health Services and Implementation Research (CBHSIR) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. The CBHSIR is based in the Division of Public Mental Health and Population Sciences. Ongoing research projects at CBHSIR include: integrated behavioral health services for persons with co-occurring psychiatric and substance use disorders; behavioral health integration in primary care; medication assisted treatment for opioid use disorders; and other implementation research projects.
Dr. Assefa is an epidemiologist by training and has both international and domestic public health research experience in health services research with a focus on health disparities. Prior to Stanford, Dr. Assefa was a postdoctoral research fellow at the Harvard School of Public Health where she was the lead investigator for a National Institute on Minority Health and Health Disparities (NIMHD) funded supplement grant to evaluate barriers and facilitators to seeking/accessing formal and informal health services, and health beliefs and traditional practices among resettled Somali Bantu and Bhutanese refugees.
Currently, Dr. Assefa’s research is focused on implementation science, integrated behavioral health services for persons with co-occurring mental health and substance use disorders, and advancing the use of organizational measures. These measures include: measures of integrated service capacity, such as the Dual Diagnosis Capability in Addiction Treatment (DDCAT) and the Behavioral Health Integration in Medical Care (BHIMC); and the measure of contextual barriers and facilitators to the implementation processes, the Consolidated Framework for Implementation Research (CFIR) Index. -
Rania Awaad
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests As the Director of the Muslims and Mental Health Lab, Dr. Awaad is dedicated to creating an academic home for the study of mental health as it relates to the Islamic faith and Muslim populations. The lab aims to provide the intellectual resources to clinicians, researchers, trainees, educators, community and religious leaders working with or studying Muslims.
-
Sepideh Bajestan
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Neuropsychiatry
Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
Group and Individual Psychotherapy
Impulse Control Disorders -
Tali Ball, PhD
Instructor, Psychiatry and Behavioral Sciences
Bio Tali Ball, PhD is the Director of the Stanford Translational Anxiety Research (STAR) Lab and an Instructor in the Stanford Department of Psychiatry and Behavioral Sciences. Her primary research aim is to translate neurobiologically-based models of anxiety into improved treatment outcomes. She received her PhD in Clinical Psychology from the SDSU/UCSD Joint Doctoral Program, where her dissertation work established relationships between brain activation during fear extinction learning and anxiety reduction following a brief exposure intervention. Her postdoctoral research focused on developing clinically useful metrics of brain circuit function and incorporating neuroscience-based assessments into clinical practice. Her work brings together clinical psychology, neuroscience, and computational approaches, always with an eye towards how the results of the science can be directly implemented in clinical practice.
-
Jacob S. Ballon
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Jacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the medical director of H2 acute inpatient unit and the co-director of the specialty psychiatry clinics section in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.
INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics.
Dr. Ballon maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He co-chairs a diverse working group that brings together researchers from throughout the university and technology community to investigate these connections and look at innovative ways to combine large-scale data to elucidate new strategies for developing pathways to prevention or treatment of psychosis. He has active projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance.
In understanding the whole-body impact of psychiatric illness, Dr. Ballon also has an active interest in the role that exercise can play in psychiatric treatment. He co-chairs Brain-Ex, a multidisciplinary research partnership of clinical research, neuroscience, exercise physiology, and prevention medicine to build the capacity to study the impact of physical exercise on brain response, reward pathways, neuroprotection, and prevention of psychiatric disorders. This program aims to study the neurobiology of elite athletic performance, sustained exercise behavior, and the subjective experience of exercise, as well as the potential for exercise to prevent and reverse neurodegenerative psychiatric disorders. He is the site-principal investigator of an NIMH-funded clinical trial looking at the use of aerobic exercise to improve cognition in people with schizophrenia. -
Belinda Bandstra
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Belinda S. Bandstra, MD, MA, is Clinical Associate Professor, Assistant Director of Residency Training, and Chief of the General Resident Continuity Clinic in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She supervises residents in the General Clinic, Evaluation Clinic, Individual Psychotherapy Clinic and Psychosocial Treatment Clinic, in addition to maintaining a small general clinical practice of her own. Dr. Bandstra has specific interests in issues of culture in psychiatry, transitional age mental health, and mental health and wellness in academia.
Dr. Bandstra also teaches extensively in the Adult Psychiatry Residency Training Program. She co-directs residency coursework in: Sociocultural Issues in Psychiatry; Leadership, Scholarship, and Career Development; and Essentials of Psychiatry. Dr. Bandstra is a member of the Association for Academic Psychiatry and the American Association of Directors of Psychiatric Residency Training. -
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine & Senior Fellow at the Woods Institute and at the Freeman Spogli Institute
Current Research and Scholarly Interests Areas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Hemorrhagic Viruses -
Fiona Barwick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine
Current Research and Scholarly Interests Dr. Fiona Barwick’s research interests focus on expanding sleep education, improving sleep health, and adapting treatments for sleep disorders in populations where developmental, medical, psychiatric and cultural factors intersect.
She and Kevin Lee, MD, a psychiatrist at Stanford’s Counseling and Psychological Services, are currently completing an online survey of Student Sleep Habits and Health that was funded by a Psychiatry Innovation Grantion 2018. Survey results will inform the development of a cognitive-behavioral treatment protocol that will help students address sleep problems and manage sleep health.
She is collaborating with Heather Poupore-King, PhD, at Stanford’s Pain Management Center, to develop an integrated treatment protocol for improving sleep and chronic pain. With the protocol now complete, Dr. Barwick and Dr. King plan to run the six-session group throughout 2019, collecting pre-treatment, post-treatment and follow-up data to analyze outcomes.
She is working with Mitchell Miglis, MD, a Stanford neurologist who specializes in autonomic dysfunction, to adapt and refine circadian techniques and Cognitive Behavioral Therapy for Insomnia (CBT-I) for treating individuals with Postural Orthostatic Tachycardia Syndrome (POTS).
She is collaborating with Yishan Xu, PhD, and Chenyu Li, MD, to develop an integrated “East-West” protocol combining principles of Cognitive Behavioral Sleep Medicine (CBSM) with Traditional Chinese Medicine (TCM). Online and in-person groups that deliver CBSM to Mandarin speakers just started, and data will be collected during 2019 in collaboration with Chongqing Traditional Chinese Medicine Hospital. -
Catherine Benedict
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests My research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.
-
Brandon Bentzley
Postdoctoral Medical Fellow, Psychiatry
Bio Brandon received his bachelors in physics from The College of New Jersey. Upon graduating he spent a year conducting plasma physics research in a joint project between Princeton University and NASA. Brandon then turned his interests to addiction neuroscience and began his training in the Medical Scientist Training Program (MD/PhD) at the Medical University of South Carolina (MUSC). At MUSC Brandon completed his dissertation research with Gary Aston-Jones, PhD, studying the behavioral economics and neuroeconomics of drug self-administration in rats. Simultaneously, Brandon conducted clinical research on buprenorphine maintenance therapy, focusing on how patient perspectives influence treatment. Brandon is currently a resident physician in the research track in the Department of Psychiatry and Behavioral Sciences at Stanford. Brandon's current research interests focus on developing neurostimulation-based treatments for substance use disorders within a neuroeconomic framework.
-
Michele Berk
Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development) at the Stanford University Medical Center
Current Research and Scholarly Interests The focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).
-
Rebecca Bernert
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Bio Dr. Bernert is Founding Director of the Suicide Prevention Research Laboratory, and Co-Chairs a special departmental initiative to develop a Center for Premature Mortality and Suicide Prevention. She is a suicidologist, with subspecialty expertise in suicide prevention clinical trials, standardized suicide risk assessment and best practice management, and the epidemiology of self-directed violence. She has subspecialty training in behavioral sleep medicine, with a background in sleep and circadian physiology. Her program utilizes cognitive, biologic (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics. Dr. Bernert has collaborated with NIH, DOD, DARPA, SAMHSA, and CDC on suicide prevention initiatives; and recently served as a content expert for the White House 2015 Open Data and Innovation for Suicide Prevention #Hackathon. She has also contributed to the development of clinical practice parameters, including the 2013 VA/DOD Clinical Practice Guidelines for the Assessment and Management of Suicide Risk, with current work underway focused on investigating medical education training in suicide risk assessment and management. Her research focuses on the identification of novel therapeutic targets for suicide prevention across the lifespan, particularly those aiming to reduce stigma and enhance access to care. A specific focus of this work emphasizes the use of rapid-action, low-risk treatment approaches for the prevention of suicide. Dr. Bernert has several suicide prevention trials underway, funded by NIH and DOD, testing the preliminary efficacy of a non pharmacological insomnia treatment on suicidal behaviors. She also has several grants focused on the development of a data monitoring system for the study of local suicide clusters and emergency department based protocols to improve risk detection within pediatric suicide prevention. Our aim is to delineate transdiagnostic risk factors and biomarkers of clinical response that may inform the pathogenesis of risk and treatment innovation. An overarching mission is to harness new technologies within suicide prevention, including artificial intelligence (AI) and mobile health applications, to enhance risk detection and multidisciplinary frameworks. Advisory and advocacy work, and the way in which research guides health policy, dissemination, and national strategies for suicide prevention, represents an extension of this work. This includes recent initiatives to establish national and local guidelines for lethal means restriction and calls for advanced technology use in suicide prevention research and strategy. Last, Dr. Bernert has several pilot projects underway focused on inclusive practices in faculty diversity and development, and the way in which family-friendly policies impact faculty recruitment and retention in academic medicine.
-
Mahendra Bhati
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.
